222 related articles for article (PubMed ID: 6605139)
1. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.
Benson DF; Kuhl DE; Hawkins RA; Phelps ME; Cummings JL; Tsai SY
Arch Neurol; 1983 Nov; 40(12):711-4. PubMed ID: 6605139
[TBL] [Abstract][Full Text] [Related]
2. [Cerebral glucose metabolism in dementia (PET-FDG study)].
Hatazawa J; Itoh M; Matsuzawa T
Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
[TBL] [Abstract][Full Text] [Related]
3. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.
Friedland RP; Budinger TF; Ganz E; Yano Y; Mathis CA; Koss B; Ober BA; Huesman RH; Derenzo SE
J Comput Assist Tomogr; 1983 Aug; 7(4):590-8. PubMed ID: 6602819
[TBL] [Abstract][Full Text] [Related]
4. [F-18 FDG PET in dementia].
Ichiya Y
Rinsho Hoshasen; 1989 Oct; 34(11):1337-41. PubMed ID: 2601095
[TBL] [Abstract][Full Text] [Related]
5. Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease.
Kuhl DE; Metter EJ; Riege WH
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():211-26. PubMed ID: 4023401
[TBL] [Abstract][Full Text] [Related]
6. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
Farkas T; Ferris SH; Wolf AP; De Leon MJ; Christman DR; Reisberg B; Alavi A; Fowler JS; George AE; Reivich M
Am J Psychiatry; 1982 Mar; 139(3):352-3. PubMed ID: 6977276
[No Abstract] [Full Text] [Related]
7. Alzheimer's disease: focal cortical changes shown by positron emission tomography.
Foster NL; Chase TN; Fedio P; Patronas NJ; Brooks RA; Di Chiro G
Neurology; 1983 Aug; 33(8):961-5. PubMed ID: 6603596
[TBL] [Abstract][Full Text] [Related]
8. Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
Fukuyama H; Harada K; Yamauchi H; Miyoshi T; Yamaguchi S; Kimura J; Kameyama M; Senda M; Yonekura Y; Konishi J
J Neurol Sci; 1991 Dec; 106(2):128-34. PubMed ID: 1802960
[TBL] [Abstract][Full Text] [Related]
9. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.
Koss E; Friedland RP; Ober BA; Jagust WJ
Am J Psychiatry; 1985 May; 142(5):638-40. PubMed ID: 3872604
[TBL] [Abstract][Full Text] [Related]
10. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
[TBL] [Abstract][Full Text] [Related]
11. High-resolution PET studies in Alzheimer's disease.
Kumar A; Schapiro MB; Grady C; Haxby JV; Wagner E; Salerno JA; Friedland RP; Rapoport SI
Neuropsychopharmacology; 1991 Jan; 4(1):35-46. PubMed ID: 2003867
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography in aging and dementia: effect of cerebral atrophy.
Chawluk JB; Alavi A; Dann R; Hurtig HI; Bais S; Kushner MJ; Zimmerman RA; Reivich M
J Nucl Med; 1987 Apr; 28(4):431-7. PubMed ID: 3494824
[TBL] [Abstract][Full Text] [Related]
13. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
[TBL] [Abstract][Full Text] [Related]
14. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of cerebral glucose utilization in dementia.
Matsuzawa T; Matsui H; Meguro K; Ueda M; Yamada K; Yamaguchi T; Itoh M; Hatazawa J; Kinomura S
Sci Rep Res Inst Tohoku Univ Med; 1990 Dec; 37(1-4):11-21. PubMed ID: 2103655
[TBL] [Abstract][Full Text] [Related]
16. Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study.
Ichimiya A; Herholz K; Mielke R; Kessler J; Slansky I; Heiss WD
J Neurol Sci; 1994 May; 123(1-2):11-7. PubMed ID: 8064302
[TBL] [Abstract][Full Text] [Related]
17. Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia.
Sasaki M; Ichiya Y; Hosokawa S; Otsuka M; Kuwabara Y; Fukumura T; Kato M; Goto I; Masuda K
Ann Nucl Med; 1992 Nov; 6(4):241-6. PubMed ID: 1489634
[TBL] [Abstract][Full Text] [Related]
18. Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer's disease.
Cutler NR; Haxby JV; Duara R; Grady CL; Moore AM; Parisi JE; White J; Heston L; Margolin RM; Rapoport SI
Neurology; 1985 Nov; 35(11):1556-61. PubMed ID: 3877253
[TBL] [Abstract][Full Text] [Related]
19. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
Heiss WD; Szelies B; Kessler J; Herholz K
Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
